Phase 1 Study of SUL-238 Was Started in Our Clinic
Phase 1 Study of SUL-238 Was Started in Our Clinic
The Phase 1 research study of the innovative research drug SUL-238, the first member of its class, to be conducted in healthy volunteers, has started in our clinic.
We use cookies so that you can make the most of our website. By logging into this site, you are deemed to have accepted the use of cookies and our cookie policy. Please click to get detailed information about our cookie policy.